|Bid||10,340.00 x 200|
|Ask||10,350.00 x 34100|
|Day's Range||10,340.00 - 10,580.00|
|52 Week Range||103.40 - 10,580.00|
|PE Ratio (TTM)||132,564.09|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Categories: Europe Value Analsysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Teva Pharmaceutical Industries Ltd. a score of 75. Our analysis is based on comparing Teva Pharmaceutical Industries Ltd. with the following peers – Compugen Ltd. and XTL Biopharmaceuticals Ltd. (CGEN-IL and XTLB-IL). Investment Outlook Teva Pharmaceutical Industries Ltd. has a fundamental score of 75 and has a ... Read more (Read more...)
Commenting on Mylan N.V. (NASDAQ: MYL ), Barclays said there's understandably reason to be skeptical that the company will win approval for its generic version of Copaxone now after years of promises. ...
Billionaires appear to have focused on drug stocks that were mired in debt in Q1.